title: Immunization against intestinal bacterial endotoxin prevents alcoholic fatty liver in rats.
abstract: Accumulating evidences indicate that an endotoxin originating from intestinal gram-negative bacteria may be involved in alcohol-induced liver injury including fatty liver. Therefore, whether immunization against intestinal bacterial endotoxin blocked fatty liver induced by chronic alcohol and diet including much-unsaturated fatty acid was investigated in rats. The titer of antibody against the endotoxin increased significantly after 13 weeks of continuous immunization. Daily alcohol treatment was initiated at 12 weeks and continued for 4 weeks. Plasma glutamic pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT) and triglyceride (TG) levels increased significantly in non-immunized rats receiving alcohol, but not in immunized rats. Continuous alcohol treatment gradually decreased the survival rate to 60% from 13 days after beginning administration in non-immunized, but not immunized, rats. A histochemical study revealed that continuous treatment with alcohol and unsaturated fatty acids caused fatty liver in non-immunized, but not immunized, rats. This study strongly supports the hypothesis that alcohol-induced fatty liver is due to a circulating endotoxin, and suggests that immunization for endotoxin prevent the alcoholic fatty liver.
authors: Department of Veterinary Physiology, Faculty of Agriculture, University of Miyazaki, Japan.
authors: G
authors: G
authors: Nishimura
authors: K
authors: K
authors: Nakahara
authors: N
authors: N
authors: Misawa
authors: M
authors: M
authors: Muranaka
authors: K
authors: K
authors: Uchida
authors: H
authors: H
authors: Kuroda
authors: N
authors: N
authors: Murakami
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000428:Alcohol Drinking / Q000009:adverse effects; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D016207:Cytokines / Q000097:blood; D004041:Dietary Fats / Q000009:adverse effects; D005235:Fatty Liver, Alcoholic / Q000201:enzymology / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D007114:Immunization; D008070:Lipopolysaccharides / Q000097:blood / Q000276:immunology*; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000097:blood
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D016207:Cytokines; D004041:Dietary Fats; D008070:Lipopolysaccharides; D014280:Triglycerides; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase